Hepatic IFRD1 Alleviates Metabolic Dysfunction-Linked Steatohepatitis Through the GLUD1/α-KG Pathway
A groundbreaking study conducted by the research team led by Professors Jianping Weng, Sihui Luo, and Lianxin Liu at the ...
Tag: metabolic dysfunction-associated steatohepatitis treatment
New Hormone Therapies Targeting Steatohepatitis Metabolism
In the rapidly evolving landscape of metabolic diseases, metabolic dysfunction-associated steatohepatitis (MDS) has emerged as a formidable clinical challenge, stimulating ...
Novel PPARδ Agonist Halts Liver Fibrosis, Ferroptosis
In a groundbreaking development in the field of metabolic liver disorders, researchers have identified DN203316, a novel agonist for the ...
Asthma Medication Exhibits Potential to Reverse Fatty Liver Disease
Scientists at the Medical University of South Carolina (MUSC) have unveiled a promising new avenue in the fight against metabolic ...
Tirzepatide Resolves MASH Without Worsening Fibrosis
Tirzepatide, a novel therapeutic agent, has emerged as a beacon of hope for individuals grappling with metabolic dysfunction-associated steatohepatitis (MASH). ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!